Intellia Therapeutics
NTLA
#5291
Rank
C$2.06 B
Marketcap
C$17.84
Share price
-0.68%
Change (1 day)
27.07%
Change (1 year)

EPS for Intellia Therapeutics (NTLA)

EPS in 2025 (TTM): C-$6.02

According to Intellia Therapeutics's latest financial reports the company's current EPS (TTM) is C-$5.83. In 2024 the company made an earnings per share (EPS) of C-$7.17 an increase over its 2023 EPS that were of C-$7.39.

EPS history for Intellia Therapeutics from 2016 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$6.02-16.07%
2024C-$7.17-2.96%
2023C-$7.39-12.46%
2022C-$8.4464.36%
2021C-$5.1456.67%
2020C-$3.28
2018C-$2.726.99%
2017C-$2.5471.4%
2016C-$1.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$2.36-59.48%๐Ÿ‡บ๐Ÿ‡ธ USA